Macular Degeneration
14 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| ACDN-01 for stargardt disease | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ADVM-022 for wet macular degeneration | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Autologous iPSC-derived RPE for macular degeneration | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Eyecyte-RPE™ for geographic atrophy | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| NT-101 ophthalmic solution for macular degeneration | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| OCU410 for geographic atrophy | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| OLN324 for macular degeneration | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| OpRegen for geographic atrophy | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| OpRegen for macular degeneration | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Prima for geographic atrophy | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PRIMA Bionic Vision System for geographic atrophy | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| PRIMA Products for stargardt disease | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PST-611 for geographic atrophy | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| SB-007 for stargardt disease | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |